BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17962941)

  • 1. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner.
    Yaqub S; Henjum K; Mahic M; Jahnsen FL; Aandahl EM; Bjørnbeth BA; Taskén K
    Cancer Immunol Immunother; 2008 Jun; 57(6):813-21. PubMed ID: 17962941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism.
    Bryn T; Yaqub S; Mahic M; Henjum K; Aandahl EM; Taskén K
    Int Immunol; 2008 Feb; 20(2):235-45. PubMed ID: 18156149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.
    Brudvik KW; Henjum K; Aandahl EM; Bjørnbeth BA; Taskén K
    Cancer Immunol Immunother; 2012 Jul; 61(7):1045-53. PubMed ID: 22159472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients.
    Deng L; Zhang H; Luan Y; Zhang J; Xing Q; Dong S; Wu X; Liu M; Wang S
    Clin Cancer Res; 2010 Aug; 16(16):4105-12. PubMed ID: 20682706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation.
    Mahic M; Yaqub S; Bryn T; Henjum K; Eide DM; Torgersen KM; Aandahl EM; Taskén K
    J Leukoc Biol; 2008 May; 83(5):1111-7. PubMed ID: 18270250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence.
    Cui G; Yuan A; Goll R; Olsen T; Husebekk A; Vonen B; Florholmen J
    Cancer Immunol Immunother; 2007 Dec; 56(12):1993-2001. PubMed ID: 17579859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms.
    Stolfi C; Franzè E; Monteleone I; Caruso R; Franceschilli L; Sileri P; Sica GS; Gaspari AL; Del Vecchio Blanco G; Pallone F; Monteleone G
    Clin Sci (Lond); 2012 Sep; 123(5):295-306. PubMed ID: 22435743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer.
    Yang S; Wang B; Guan C; Wu B; Cai C; Wang M; Zhang B; Liu T; Yang P
    J Leukoc Biol; 2011 Jan; 89(1):85-91. PubMed ID: 20952660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage of differentiation, proliferative index of tumor cells and cytotoxic activity of peripheral blood lymphocytes in colorectal cancer patients.
    Paholyuk TD; Zacharzeva LM; Koshel KV; Oliynichenko GP; Berezhnaya NM
    Exp Oncol; 2004 Jun; 26(2):161-3. PubMed ID: 15273670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral cellular immunity in colorectal cancer patients.
    Kiewe P; Wojtke S; Thiel E; Nagorsen D
    Hum Immunol; 2009 Feb; 70(2):85-8. PubMed ID: 19133306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence.
    Yuan A; Steigen SE; Goll R; Vonen B; Husbekk A; Cui G; Florholmen J
    APMIS; 2008 Jun; 116(6):445-56. PubMed ID: 18754318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Jin J; Li XY; Zhou le D; Huo Z; Zhou JH; Chen W
    Digestion; 2009; 79(3):169-76. PubMed ID: 19329856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
    Battaglia A; Buzzonetti A; Baranello C; Ferrandina G; Martinelli E; Fanfani F; Scambia G; Fattorossi A
    Cancer Immunol Immunother; 2009 Sep; 58(9):1363-73. PubMed ID: 19172271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 15-lipoxygenase-1 expression may enhance the sensitivity to non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancers from patients who are treated with the compounds.
    Yoshinaga M; Murao H; Kitamura Y; Koga K; Tsuruta S; Igarashi H; Nakamura K; Takayanagi R
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2324-9. PubMed ID: 17559385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.
    Stolfi C; Fina D; Caruso R; Caprioli F; Sarra M; Fantini MC; Rizzo A; Pallone F; Monteleone G
    Biochem Pharmacol; 2008 Feb; 75(3):668-76. PubMed ID: 17981262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.